drugset / Trial / NCT05681403
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
This is a single arm, open, single-center clinical study. The patients who are diagnosed with lymphoma and intend to undergo ASCT will be enrolled. The aim of this study is to investigate the efficacy and safety of the conditioning regimen using mitoxantrone hydrochloride liposome, BCNU, etoposide and cytarabine for ASCT.
Timeline
- Start
- 2023-01-15
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Mitoxantrone | Small molecule | — | — |
| Subject | carmostine | Unknown | — | — |